Profile

    Corporate information

    Investment activity status
    Active investor

    Company type

    Reseearch venture of the Zambon group.

    Investment preferences

    Selected investments

    Country Date Notes
    Mission Bay Capital III
    16 Sep 2019 Fund Closing
    Active
    SuppreMol GmbH
    biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases.
    1 May 2006 Series A
    Initial investment. Round participant. Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.